54 related articles for article (PubMed ID: 17552363)
1. Degenerate binding of tyrosinase peptides to MHC II Ad/Ed molecules.
Mittelman A; Lucchese G; Stufano A; Kanduc D
J Exp Ther Oncol; 2007; 6(3):231-9. PubMed ID: 17552363
[TBL] [Abstract][Full Text] [Related]
2. Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis.
Willers J; Lucchese A; Mittelman A; Dummer R; Kanduc D
Exp Dermatol; 2005 Jul; 14(7):543-50. PubMed ID: 15946243
[TBL] [Abstract][Full Text] [Related]
3. Proteome-based epitopic peptide scanning along PSA.
Stufano A; Kanduc D
Exp Mol Pathol; 2009 Feb; 86(1):36-40. PubMed ID: 19109947
[TBL] [Abstract][Full Text] [Related]
4. Toward prediction of class II mouse major histocompatibility complex peptide binding affinity: in silico bioinformatic evaluation using partial least squares, a robust multivariate statistical technique.
Hattotuwagama CK; Toseland CP; Guan P; Taylor DJ; Hemsley SL; Doytchinova IA; Flower DR
J Chem Inf Model; 2006; 46(3):1491-502. PubMed ID: 16711768
[TBL] [Abstract][Full Text] [Related]
5. Peptide-binding motif prediction by using phage display library for SasaUBA*0301, a resistance haplotype of MHC class I molecule from Atlantic Salmon (Salmo salar).
Zhao H; Hermsen T; Stet RJ; Skjødt K; Savelkoul HF
Mol Immunol; 2008 Mar; 45(6):1658-64. PubMed ID: 18206244
[TBL] [Abstract][Full Text] [Related]
6. Novel peptides with tyrosinase inhibitory activity.
Schurink M; van Berkel WJ; Wichers HJ; Boeriu CG
Peptides; 2007 Mar; 28(3):485-95. PubMed ID: 17241698
[TBL] [Abstract][Full Text] [Related]
7. An in silico immunological approach for prediction of CD8+ T cell epitopes of Leishmania major proteins in susceptible BALB/c and resistant C57BL/6 murine models of infection.
Guerfali FZ; Ben-Abdallah H; Sghaier RM; Ben-Aissa K; Mkannez G; Attia H; Laouini D
Infect Genet Evol; 2009 May; 9(3):344-50. PubMed ID: 18420466
[TBL] [Abstract][Full Text] [Related]
8. A Bayesian regression approach to the prediction of MHC-II binding affinity.
Zhang W; Liu J; Niu YQ; Wang L; Hu X
Comput Methods Programs Biomed; 2008 Oct; 92(1):1-7. PubMed ID: 18562039
[TBL] [Abstract][Full Text] [Related]
9. Conformation of MHC class II I-A(g7) is sensitive to the P9 anchor amino acid in bound peptide.
Gardiner A; Richards KA; Sant AJ; Arneson LS
Int Immunol; 2007 Sep; 19(9):1103-13. PubMed ID: 17855434
[TBL] [Abstract][Full Text] [Related]
10. Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.
Hou T; Zhang W; Case DA; Wang W
J Mol Biol; 2008 Feb; 376(4):1201-14. PubMed ID: 18206907
[TBL] [Abstract][Full Text] [Related]
11. Exogenous CLIP localizes into endocytic compartment of cells upon internalization: implications for antigen presentation by MHC class II molecules.
Mukherjee R; Chaturvedi P; Lee-Chan E; Singh B
Mol Immunol; 2008 Apr; 45(8):2166-76. PubMed ID: 18279957
[TBL] [Abstract][Full Text] [Related]
12. The basidiomycetous mushroom Lentinula edodes white collar-2 homolog PHRB, a partner of putative blue-light photoreceptor PHRA, binds to a specific site in the promoter region of the L. edodes tyrosinase gene.
Sano H; Kaneko S; Sakamoto Y; Sato T; Shishido K
Fungal Genet Biol; 2009 Apr; 46(4):333-41. PubMed ID: 19344689
[TBL] [Abstract][Full Text] [Related]
13. Structural analysis of the adenovirus type 2 E3/19K protein using mutagenesis and a panel of conformation-sensitive monoclonal antibodies.
Menz B; Sester M; Koebernick K; Schmid R; Burgert HG
Mol Immunol; 2008 Nov; 46(1):16-26. PubMed ID: 18692902
[TBL] [Abstract][Full Text] [Related]
14. Arthritogenic T cell epitope in glucose-6-phosphate isomerase-induced arthritis.
Iwanami K; Matsumoto I; Tanaka Y; Inoue A; Goto D; Ito S; Tsutsumi A; Sumida T
Arthritis Res Ther; 2008; 10(6):R130. PubMed ID: 18992137
[TBL] [Abstract][Full Text] [Related]
15. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
[TBL] [Abstract][Full Text] [Related]
16. Flexibility of the MHC class II peptide binding cleft in the bound, partially filled, and empty states: a molecular dynamics simulation study.
Yaneva R; Springer S; Zacharias M
Biopolymers; 2009 Jan; 91(1):14-27. PubMed ID: 18767126
[TBL] [Abstract][Full Text] [Related]
17. Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100.
van Stipdonk MJ; Badia-Martinez D; Sluijter M; Offringa R; van Hall T; Achour A
Cancer Res; 2009 Oct; 69(19):7784-92. PubMed ID: 19789338
[TBL] [Abstract][Full Text] [Related]
18. The peptide length specificity of some HLA class I alleles is very broad and includes peptides of up to 25 amino acids in length.
Bell MJ; Burrows JM; Brennan R; Miles JJ; Tellam J; McCluskey J; Rossjohn J; Khanna R; Burrows SR
Mol Immunol; 2009 May; 46(8-9):1911-7. PubMed ID: 19157553
[TBL] [Abstract][Full Text] [Related]
19. Amino acid requirement for the high affinity binding of a selected arginine-rich peptide with the HIV Rev-response element RNA.
Sugaya M; Nishino N; Katoh A; Harada K
J Pept Sci; 2008 Aug; 14(8):924-35. PubMed ID: 18351707
[TBL] [Abstract][Full Text] [Related]
20. Adsorption behavior of linear and cyclic genetically engineered platinum binding peptides.
Seker UO; Wilson B; Dincer S; Kim IW; Oren EE; Evans JS; Tamerler C; Sarikaya M
Langmuir; 2007 Jul; 23(15):7895-900. PubMed ID: 17579466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
